GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Prostatype Genomics AB (OSTO:PROGEN) » Definitions » Sale Of Property, Plant, Equipment

Prostatype Genomics AB (OSTO:PROGEN) Sale Of Property, Plant, Equipment : kr0.00 Mil (TTM As of Dec. 2024)


View and export this data going back to 2020. Start your Free Trial

What is Prostatype Genomics AB Sale Of Property, Plant, Equipment?

Prostatype Genomics AB's sale of property, plant, equipment for the six months ended in Dec. 2024 was kr0.00 Mil. It means Prostatype Genomics AB gained kr0.00 Mil from selling property, plant, and equipment. Prostatype Genomics AB's sale of property, plant, equipment for the trailing twelve months (TTM) ended in Dec. 2024 was kr0.00 Mil.

Compared with last quarter (kr0.00 Mil in Jun. 2024 ), Prostatype Genomics AB gained the same money from selling property, plant, and equipment in Dec. 2024 (kr0.00 Mil).

Prostatype Genomics AB Sale Of Property, Plant, Equipment Historical Data

The historical data trend for Prostatype Genomics AB's Sale Of Property, Plant, Equipment can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Prostatype Genomics AB Sale Of Property, Plant, Equipment Chart

Prostatype Genomics AB Annual Data
Trend Jun18 Jun19 Dec21 Dec22 Dec23 Dec24
Sale Of Property, Plant, Equipment
Get a 7-Day Free Trial - - - - -

Prostatype Genomics AB Semi-Annual Data
Jun18 Jun19 Jun20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24
Sale Of Property, Plant, Equipment Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only - - - - -

Prostatype Genomics AB Sale Of Property, Plant, Equipment Calculation

The amount earned to sell PPE.

Sale Of Property, Plant, Equipment for the trailing twelve months (TTM) ended in Dec. 2024 adds up the semi-annually data reported by the company within the most recent 12 months, which was kr0.00 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Prostatype Genomics AB Sale Of Property, Plant, Equipment Related Terms

Thank you for viewing the detailed overview of Prostatype Genomics AB's Sale Of Property, Plant, Equipment provided by GuruFocus.com. Please click on the following links to see related term pages.

Prostatype Genomics AB Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Prostatype Genomics AB (OSTO:PROGEN) » Definitions » Sale Of Property, Plant, Equipment
Comparable Companies
XSAT:SPERM NGM:ATANA NGM:LEVBIO XSAT:GEAN TMO DHR XSWX:LONN IDXX A IQV SHSE:603259 MTD NTRA WAT DGX LH XPAR:BIM ILMN ICLR RVTY
Traded in Other Exchanges
N/A
Address
Gustaf III:s Boulevard 34, Solna, SWE, 169 73
Website
https://www.prostatypegenomics.com
Prostatype Genomics AB manufactures, markets and sells the prognostic gene test Prostatype. By assessing the aggressiveness of prostate cancer, Prostatype helps clinicians and patients to make correct treatment decisions. Over and under treatment of prostate cancer can be minimized, the quality of life for the patient improved and money can be saved for the health care sector.

Prostatype Genomics AB Headlines

No Headlines